1-4 of 4
Yoshihiro Hayakawa
Close
Sort by
Journal Articles

Increased Marrow CD57+ Cytotoxic T Cells Is a Powerful Prognostic Marker for Survival in Patients with Relapsed Multiple Myeloma (MM) Receiving Thalidomide.

Linda R. Mileshkin, MBBS, FRACP, Peter Gambell, PhD, Victoria Beshay, PhD, Yoshihiro Hayakawa, PhD, Mark Smyth, PhD, Melanie Trivett, PhD, Paul J. Simmons, PhD, Alvin Milner, PhD, Astat, Jerome B. Zeldis, MD, FACP, Miles Prince, MD, FRACP
Journal: Blood
Blood (2005) 106 (11): 3486.
https://doi.org/10.1182/blood.V106.11.3486.3486
Published: 2005
Journal Articles

IFN-γ–mediated negative feedback regulation of NKT-cell function by CD94/NKG2

Tsuyoshi Ota, Kazuyoshi Takeda, Hisaya Akiba, Yoshihiro Hayakawa, Kouetsu Ogasawara, Yoshinori Ikarashi, Sachiko Miyake, Hiro Wakasugi, Takashi Yamamura, Mitchell Kronenberg, David H. Raulet, Katsuyuki Kinoshita, Hideo Yagita, Mark J. Smyth, Ko Okumura
Journal: Blood
Blood (2005) 106 (1): 184–192.
https://doi.org/10.1182/blood-2004-11-4257
Published: 2005
Journal Articles

RETRACTED: TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver

Kazuyoshi Takeda, Erika Cretney, Yoshihiro Hayakawa, Tsuyoshi Ota, Hisaya Akiba, Kouetsu Ogasawara, Hideo Yagita, Katsuyuki Kinoshita, Ko Okumura, Mark J. Smyth
Journal: Blood
Blood (2005) 105 (5): 2082–2089.
https://doi.org/10.1182/blood-2004-08-3262
Published: 2005
Journal Articles

IFN-γ–mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide

Yoshihiro Hayakawa, Kazuyoshi Takeda, Hideo Yagita, Mark J. Smyth, Luc Van Kaer, Ko Okumura, Ikuo Saiki
Journal: Blood
Blood (2002) 100 (5): 1728–1733.
https://doi.org/10.1182/blood.V100.5.1728.h81702001728_1728_1733
Published: 2002